[STARTUPS]■ STORY TIMELINE

BYTEDANCE AI DRUG SPINOFF RAISES $290M AT $1.5B

Anew Labs, a Shanghai-based artificial intelligence drug discovery startup spun off from ByteDance, secured $290 million in funding from investors including HSG and IDG Capital, valuing the company at $1.5 billion.

1 SOURCEFIRST SEEN SEP 16, 06:30 AM► READ THE ARTICLE

Techmeme+0m

Sources: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation (Kane Wu/Reuters)

Kane Wu / Reuters: Sources: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from…

◄ BACK TO ARTICLE